.jpg "Vernon K. Sondak, MD photo")
Chair, Department of Cutaneous Oncology
Moffitt Cancer Center
Tampa, FL, United States
VERNON K SONDAK MD is Chair of the Department of Cutaneous Oncology at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. He holds the Richard M. Schulze Family Foundation Distinguished Endowed Chair in Cutaneous Oncology there, and is Professor in the Departments of Oncologic Sciences and Surgery at the University of South Florida Morsani College of Medicine. Since 2004, when he came to Tampa, the Moffitt Cutaneous Oncology Clinic has grown into one of the largest multidisciplinary treatment centers for melanoma and other skin cancers in the world, now seeing well over 2000 new patients each year. Dr. Sondak is Principal Investigator of the Moffitt Skin SPORE. His research interests include surgical treatment of melanoma in adults and children; surgical treatment of Merkel cell carcinoma, DFSP and other cutaneous tumors; adjuvant and neoadjuvant therapy of melanoma; and evaluation of new therapies for patients with localized or disseminated melanoma. Dr. Sondak has been a leader in studies of surgical treatment of melanoma and other cutaneous malignancies, particularly in the application of sentinel lymph node biopsy and node dissection to the staging and treatment of melanoma and Merkel cell carcinoma, and has been instrumental in training many surgical oncologists in these techniques over the years. He is a member of the National Cancer Institute’s Board of Scientific Counselors for Clinical Sciences and Epidemiology, the group responsible for peer review and oversight of the NCI’s intramural research program. He is also an external advisor to several SPORE grants at other US institutions. Dr Sondak is the author or coauthor of over 420 articles in peer-reviewed publications, 230 abstracts, and 8 books and 82 book chapters. He has served as a peer reviewer for virtually all of the most prestigious surgery, oncology and dermatology journals.
Updated 12/16/2021
Disclosure information not submitted.
Monday, February 28, 2022
4:20 PM – 4:35 PM CST